HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation.

Abstract
Human Burkitt lymphomas are divided into two main clinical variants: the endemic form, affecting African children infected with malaria and the Epstein-Barr virus, and the sporadic form, distributed across the rest of the world. However, whereas sporadic translocations decapitate Myc from 5' proximal regulatory elements, most endemic events occur hundreds of kilobases away from Myc. The origin of these rearrangements and how they deregulate oncogenes at such distances remain unclear. We here recapitulate endemic Burkitt lymphoma-like translocations in plasmacytomas from uracil N-glycosylase and activation-induced cytidine deaminase-deficient mice. Mapping of translocation breakpoints using an acetylated histone H3 lysine 9 chromatin immunoprecipitation sequencing approach reveals Igh fusions up to ∼350 kb upstream of Myc or the related oncogene Mycn. A comprehensive analysis of epigenetic marks, PolII recruitment, and transcription in tumor cells demonstrates that the 3' Igh enhancer (Eα) vastly remodels ∼450 kb of chromatin into translocated sequences, leading to significant polymerase occupancy and constitutive oncogene expression. We show that this long-range epigenetic reprogramming is directly proportional to the physical interaction of Eα with translocated sites. Our studies thus uncover the extent of epigenetic remodeling by Ig 3' enhancers and provide a rationale for the long-range deregulation of translocated oncogenes in endemic Burkitt lymphomas. The data also shed light on the origin of endemic-like chromosomal rearrangements.
AuthorsAlexander L Kovalchuk, Camilo Ansarah-Sobrinho, Ofir Hakim, Wolfgang Resch, Helena Tolarová, Wendy Dubois, Arito Yamane, Makiko Takizawa, Isaac Klein, Gordon L Hager, Herbert C Morse 3rd, Michael Potter, Michel C Nussenzweig, Rafael Casellas
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 109 Issue 27 Pg. 10972-7 (Jul 03 2012) ISSN: 1091-6490 [Electronic] United States
PMID22711821 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Oncogene Proteins, Fusion
  • Cytidine
  • Uracil-DNA Glycosidase
Topics
  • Animals
  • B-Lymphocytes (cytology, physiology)
  • Burkitt Lymphoma (epidemiology, genetics)
  • Cells, Cultured
  • Cytidine (genetics)
  • Disease Models, Animal
  • Endemic Diseases
  • Enhancer Elements, Genetic (genetics)
  • Epigenesis, Genetic (genetics)
  • Gene Expression Regulation, Neoplastic (genetics)
  • Gene Rearrangement, B-Lymphocyte (genetics)
  • Genes, Immunoglobulin Heavy Chain (genetics)
  • Genes, myc (genetics)
  • Humans
  • Immunoglobulin Class Switching (genetics)
  • Mice
  • Oncogene Proteins, Fusion (genetics)
  • Plasma Cells (cytology, physiology)
  • Transcription Initiation Site (physiology)
  • Translocation, Genetic (genetics)
  • Uracil-DNA Glycosidase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: